Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Operating Income (2016 - 2026)

Ekso Bionics Holdings has reported Operating Income over the past 14 years, most recently at -$4.5 million for Q4 2025.

  • On a quarterly basis, Operating Income fell 102.2% to -$4.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$13.3 million, a 27.4% decrease, with the full-year FY2025 number at -$13.3 million, down 27.4% from a year prior.
  • Operating Income reached -$4.5 million in Q4 2025 per EKSO's latest filing, down from -$1.4 million in the prior quarter.
  • The five-year high for Operating Income was -$1.4 million in Q3 2025, with the low at -$4.6 million in Q4 2021.
  • The 5-year median for Operating Income is -$3.4 million (2021), against an average of -$3.4 million.
  • The largest YoY upside for Operating Income was 46.87% in 2025 against a maximum downside of 102.2% in 2025.
  • Tracing EKSO's Operating Income over 5 years: stood at -$4.6 million in 2021, then rose by 2.55% to -$4.4 million in 2022, then rose by 22.25% to -$3.4 million in 2023, then soared by 35.34% to -$2.2 million in 2024, then crashed by 102.2% to -$4.5 million in 2025.
  • According to Business Quant data, Operating Income over the past three periods came in at -$4.5 million, -$1.4 million, and -$4.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.